Get notified of page updates
State Advocacy Initiatives
Learn about FORCE’s state advocacy efforts in the areas of access to care, research funding, insurance and privacy by signing up for our community newsletter.

State Public Policy Initiatives

FORCE is engaged in a variety of state legislative initiatives—affordable access to genetic testing, high-risk “supplemental” cancer screenings, fertility treatments and cancer therapies, banning genetic discrimination, etc.—representing the unique needs of individuals with or at risk of hereditary cancer.

Note: The 2025 state legislative sessions are just beginning. Policy efforts will be added as they emerge.

in progress

Genetic counselor licensure

Legslation will facilitate state licensure of genetic counselors by the American Board of Genetic Counseling (ABGC). 

in progress

High-risk breast screenings and diagnostic tests

HB1061 will require that health insurers cover medically appropriate breast screenings (breast mammograms, MRIs and ultrasounds) for women at increased risk of breast cancer and diagnostic services with no patient cost-sharing. 

in progress

Protections against genetic discrimination

Legislation will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

in progress

Fertility preservation

Legislation will facilitate Medicaid and private/commercial insurance coverage of the diagnosis and treatment of infertility, including medically appropriate fertility preservation and in-vitro fertilization (IVF).

in progress

Genetic Testing

SB406 will require health insurers to cover genetic counseling and testing with no patient cost-sharing.

in progress

High-risk breast screenings and diagnostic tests

Bill will expand and improve current statutes, requiring private/commercial health insurers to cover breast screenings (breast MRIs, diagnostic mammograms and ultrasounds) for individuals with a family history of cancer or additional factors that may increase their cancer risk with no cost-sharing for the patient. 

in progress

Fertility Services

A5000/S3831 will facilitate Medicaid coverage of fertility preservation services for individuals facing infertility caused by medically necessary treatments.

in progress

High-risk prostate cancer screening

A1841/S3060 will require private/commercial health insurers to cover prostate screenings with no patient cost-sharing for individuals considered at increased risk. 

in progress

Genetic counselor licensure

A183 will establish a state board for genetic counseling and licensure of genetic counselors. 

in progress

Genetic testing

S520 will ensure ovarian cancer survivors have insurance coverage for medically necessary coverage of genetic and biomarker testing.

in progress

Protections against genetic discrimination

Legislation will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations. 

in progress

Genetic testing and associated cancer screenings

SB109 will require health insurers to cover genetic testing and evidence-based cancer screenings for individuals at increased cancer risk with no patient cost-sharing.

in progress

Protections against genetic discrimination

H2357 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

in progress

Genetic counselor licensure

HB1503/SB642 will facilitate the licensing and regulation of genetic counselors.

in progress

Fertility Services

SB333 will require Medicaid coverage of fertility preservation for individuals diagnosed with cancer who need treatment that may cause a substantial risk of infertility.

in progress

High-risk breast screenings and diagnostic tests

HB230 will require private/commercial health insurers to cover breast screenings (breast MRIs, diagnostic mammograms and breast ultrasounds) with no patient cost-sharing for individuals with a family history of cancer or who have additional factors that may increase their cancer risk.